New York Office of Cannabis Management and Montefiore
#77
Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
This article matters for clinicians and their patients as it announces a symposium focused on cannabinoids in clinical practice and research, organized by the New York Office of Cannabis Management and Montefiore Einstein. The event aims to discuss evidence-based clinical applications and emerging trends, which could provide valuable insights for healthcare professionals in managing patient care related to cannabis use.
The New York Office of Cannabis Management and Montefiore Einstein have opened registration for a two-day symposium focusing on cannabinoids in clinical practice and research. Topics are anticipated to cover evidence-based clinical applications and emerging research, with potential implications for clinicians managing patients using cannabis-based treatments.
“As a seasoned family physician specializing in cannabis medicine, I am eagerly anticipating the insights from the New York Office of Cannabis Management’s symposium. The potential for cannabinoids in clinical practice and research is promising, yet it’s crucial to approach these developments with a discerning eye, ensuring that our understanding remains grounded in evidence-based applications.”
🔬 A new symposium, co-hosted by the New York Office of Cannabis Management and Montefiore Einstein, focuses on “Cannabinoids in Clinical Practice and Research.” This event promises to delve into evidence-based clinical applications and emerging research in the field. While the complexity of cannabis as a therapeutic agent is well-known, with numerous potential benefits and risks, it’s crucial for healthcare providers to stay informed about the latest findings. As the legal landscape continues to evolve, understanding the role of cannabinoids in clinical practice can help providers make more informed decisions when discussing treatment options with patients. This symposium could provide valuable insights that may ultimately improve patient care in the realm of cannabis-related therapies.
💬 Join the Conversation
Have a question about how this applies to your situation?
Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers?
Join the forum discussion →
Have thoughts on this? Share it:

